BamSEC and AlphaSense Join Forces
Learn More

Protalix BioTherapeutics Inc. – Underwriting Agreements

NYSE American: PLX    
Share price (3/24/26): $2.07    
Market cap (3/24/26): $167 million

Underwriting Agreements Filter

EX-1.1
from 8-K 3 pages Reference Is Made to the at the Market Offering Agreement, Dated as of February 27, 2023, as Amended on March 17, 2025 (The “Atm Agreement”), Between Protalix Biotherapeutics, Inc. (The “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”). This Letter (The “Amendment”) Constitutes an Agreement Between the Company and Wainwright to Amend the Atm Agreement as Set Forth Herein. Defined Terms That Are Used but Not Defined Herein Shall Have the Meanings Ascribed to Such Terms in the Atm Agreement. 1. the Defined Term “Agreement” in the Atm Agreement Is Amended to Mean the Atm Agreement as Amended by This Amendment. 2. the First Sentence in the Third Paragraph of the Atm Agreement Is Hereby Amended and Restated as Follows
12/34/56
EX-1.1
from 8-K 3 pages ​ ​ March 17, 2025 ​ Protalix Biotherapeutics, Inc. 2 University Plaza, Suite 100 Hackensack, New Jersey 07601 Attention: Eyal Rubin, Chief Financial Officer ​ Dear Mr. Rubin: ​
12/34/56
EX-1.1
from 8-K 29 pages Protalix Biotherapeutics, Inc. Common Stock ($0.001 Par Value) at the Market Offering Agreement
12/34/56
EX-1.1
from 8-K 3 pages ​ ​ May 2, 2022 ​ Protalix BioTherapeutics 2 University Plaza, Suite 100 Hackensack, New Jersey 07601 Attention: Eyal Rubin, Chief Financial Officer ​ Dear Mr. Rubin: ​
12/34/56
EX-1.1
from 8-K 30 pages Protalix Biotherapeutics, Inc. Common Stock ($0.001 Par Value) at the Market Offering Agreement
12/34/56
EX-1.1
from 8-K 37 pages Protalix Biotherapeutics, Inc. (A Delaware Corporation) 7,608,695 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 29 pages Protalix Biotherapeutics, Inc. Common Stock ($0.001 Par Value) Atm Equity Offeringsm Sales Agreement
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement
12/34/56
EX-1
from SC 13G 1 page Exhibit 1 Joint Filing Agreement
12/34/56
EX-1.1
from 8-K 36 pages Protalix Biotherapeutics, Inc. 4,500,000 Shares Common Stock ($0.001 Par Value) Underwriting Agreement
12/34/56
EX-1.1
from 8-K 33 pages Protalix Biotherapeutics, Inc. 4,000,000 Shares Common Stock ($0.001 Par Value) Underwriting Agreement
12/34/56
EX-1.1
from 8-K 30 pages Underwriting Agreement
12/34/56